Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Shu-Feng Zhou

Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL33612, USA

Biography

Dr. Zhou is a professor in the School of Health Sciences at the Royal Melbourne Institute of Technology RMIT University in Australia. Having originally studied and practiced clinical medicine in China he undertook his PhD in pharmacology at the University of Auckland, New Zealand and has also worked at the National University of Singapore and the Queensland University of Technology. He is currently affiliated with the WHO Collaborating Center for Traditional Medicine. 
Publications

Protein Kinase Inhibitors for Clinical Targeted Cancer Treatment

Xiao-Wu Chen, Jiazhi Sun and Shu-Feng Zhou

Editorial: Clin Pharmacol Biopharm 2013, 2:e112

DOI: 10.4172/2167-065X.1000e112

Peer-reviewed Full Article Peer-reviewed Article PDF

Top